| |
original article |
Date |
Title |
Authors All Authors |
| 1 |
[GO] |
2024―Apr―15 |
Safety and Efficacy of Treatments for COVID-19: A Pharmacovigilance Perspective |
Estrada Valdés Ana Karla, Santillán Benítez Jonnathan Guadalupe |
| 2 |
[GO] |
2023―Dec―08 |
COVID-19: The Analysis, Impact and New Specified Algorithms for COVID- 19 Prevention, Cure and Possible Vaccination Path |
Furqan Yaqub khan, Irfan Ahmad, Danish Muzzaffar |
| 3 |
[GO] |
2023―Oct―05 |
Epidemiological and Demographic Analysis of Suspected Covid-19 Cases Confirmed by PCR at Medical Center ISSEMyM Toluca from March 2019 to December 2022 |
Sánchez-Flores Jesús Enrique, Santillán-Benítez Jonnathan Guadalupe |
| 4 |
[GO] |
2023―Apr―27 |
Should Children be Vaccinated Against Sars-Cov-2? |
Joseph Angel de Soto |
| 5 |
[GO] |
2023―Apr―27 |
Pandemic “Covid-19 - Postcovid Syndrome”: A System Method of Leeching is a New and Effective Treatment |
Krashenyuk AI |
| 6 |
[GO] |
2023―Mar―31 |
COVID-19 and HIV in Nigeria |
Opeyemi Folorunso |
| 7 |
[GO] |
2023―Jan―24 |
Preparation of Nitric Oxide Releasing Solution and Assessment of in Vitro Efficacy on Sars-Cov-2 Virus Using Plaque Assay |
Mansi Desai |
| 8 |
[GO] |
2022―Dec―20 |
Clinical Characteristics of Pregnant Women with Sars-Cov2 Infection in the 3rd Trimester of Pregnancy |
Lopez-Gorosabel C |
| 9 |
[GO] |
2022―Sep―29 |
Clinical Characteristics of Pregnant Women with Sars-Cov2 Infection in the 3rd Trimester of Pregnancy |
Lopez-Gorosabel C |
| 10 |
[GO] |
2022―Sep―26 |
Sars-Cov-2 and COVID-19: Epidemiological, Diagnostic, and Therapeutic Aspects in Pointe-Noire, Republic of the Congo |
Luc Magloire Anicet Boumba |
| 11 |
[GO] |
2022―Sep―26 |
Sars-Cov-2 and COVID-19: Epidemiological, Diagnostic, and Therapeutic Aspects in Pointe-Noire, Republic of the Congo |
Luc Magloire Anicet Boumba |
| 12 |
[GO] |
2022―Mar―31 |
COVID-19 Presenting as an Acute Myopericarditis: A Case Report Study |
Ibrar Anjum |
| 13 |
[GO] |
2022―Mar―31 |
An Analysis of Vaccine Research, Development, and Distribution with Specific Focus on Covid-19 Vaccine Information and Development |
Emma Kathleen Moore |
| 14 |
[GO] |
2022―Mar―31 |
Evaluation of Mutagenicity of Covid-19 Virus And The Effect Of Morphine In Its Treatment |
Ali Khanifar |
| 15 |
[GO] |
2022―Mar―31 |
Coronavirus among Acute Diseases Patients in Africa |
Abdulrehman Ibrahim Hus |
| 16 |
[GO] |
2022―Mar―31 |
Determination of SARS-CoV-2 Antispike Immunoglobulin G Level after First Dose of Oxford-AstraZeneca Vaccine among Healthcare Workers in Khartoum State |
Khansa Gasim Sabahalkheir Abdaltam |
| 17 |
[GO] |
2022―Mar―31 |
The Origin of the Sars-Cov-2 in the United States as a Biological Weapon |
Joseph Angel De Soto |
| 18 |
[GO] |
2022―Mar―31 |
Public Health Concerns of SARS-CoV-2 Omicron Variant: What We Know So Far! |
Seyi Samson Enitan |
| 19 |
[GO] |
2022―Jan―11 |
Impact of the Coved 19 Pandemic on the Core Functions of Primary Care: A Qualitative Study in the National Guard Primary Care Physicians at Western Region of Saudi Arabia 2021 |
Sameer Rizg |
| 20 |
[GO] |
2021―Jul―27 |
Personal Protective Equipment Interventions in the Era of COVID-19 Pandemics |
Porntep Siriwanarangsun, Attapon Cheepsattayakorn |
| 21 |
[GO] |
2021―Jul―27 |
Predictive Prevalence of Risk Phenotypes Associated With rs2285666 Single Nucleotide Polymorphism of ACE2 in the World Population Susceptible to SARS-CoV-2 Infection |
Mohitosh Biswas |
| 22 |
[GO] |
2021―Jul―27 |
Recurrent SARS-CoV-2 Infection: Case Reports and Review of the Literature |
Brian Conway |
| 23 |
[GO] |
2021―Jul―27 |
Vaccine Antipathy thru SARS-CoV-2 Pandemic: A Systematic Review of Roots and Results |
Saeed Shoja Shafti |
| 24 |
[GO] |
2021―Jan―28 |
Clinical Manifestation and Epidemiological Impacts of Pandemic Zoonotic Disease of the Novel Corona Virus (COVID-19) |
Firew Admasu Hailu, Tsion Admasu Hailu, Rodas Firew Admasu |
| 25 |
[GO] |
2021―Jan―28 |
The Pathophysiology of COVID-19 |
Joseph Angel de Soto, Shazia Tabassum Hakim, Frederick Tilghman Boyd |
| 26 |
[GO] |
2021―Jan―28 |
Therapeutic Role of Dipeptidyl Peptidase-4 Inhibitors in COVID-19 |
Nasser Mikhail, Soma Wali |
| 27 |
[GO] |
2021―Jan―28 |
Case Report on Reinfection Case of COVID-19 |
Abdulwahab Meqbel |
| 28 |
[GO] |
2021―Jan―28 |
Novel Coronavirus Disease 2019 (COVID-19) and Combined Autoimmune Neutropenia (AIN) and Thrombocytopenia (ITP): A Case Report and Literature Review |
Rizvi M, Medar S |
| 29 |
[GO] |
2021―Jan―28 |
Anomalous Magnetic Fields Corona Virus COVID-19 Cause |
Nikola Trfiunovic |
| 30 |
[GO] |
2021―Jan―28 |
Study of the Safety and Efficacy of the Hydroxychloroquine Protocol against COVID-19 in Algeria: Experience of the Gynaecology Department of the EHU Oran |
Toumi H, Sharif FZ, Mansur S |
| 31 |
[GO] |
2021―Jan―28 |
Thailand’s Experience in Phylogenetic Analysis of First Wave COVID-19 Outbreak |
Attapon Cheepsattayakorn, Ruangrong Cheepsattayakorn |
| 32 |
[GO] |
2021―Jan―28 |
Medical Advice Through Mobil Phone During the COVID-19 Pandemia, June - July 2020 at Nicaragua |
Francisco Medrano, Patricia Castro, Jose Antonio Vásquez |
| 33 |
[GO] |
2021―Jan―28 |
A New Trend in Dealing with Coronavirus Disease (COVID-19) Pandemic |
Majid Mohammed Mahmood |
| 34 |
[GO] |
2021―Jan―28 |
Vaccine Design through Machine Learning and Nanotechnology to Terminate COVID-19 Pandemic |
Hyunjo Kim, Jae-Hoon Song |
| 35 |
[GO] |
2021―Jan―28 |
Improved Recovery and Survival with Trimethoprim or Cotrimoxazole in Patients with Severe COVID-19: A Retrospective Analysis |
Veronica A.Varney, Thomas John, Thomas Samuel |
| 36 |
[GO] |
2021―Jan―28 |
The Use of the Available Research Evidence to Crack the Padlock of Sars-CoV-2 |
Aamir Jalal Al Mosawi |
| 37 |
[GO] |
2021―Jan―28 |
Investigation of the Level of Public Awareness Outcome of COVID -19 Pandemic among Nigerians |
Azuonwu Obioma, Ihua Nnenna, Ahiakwo Christian |
| 38 |
[GO] |
2021―Jan―28 |
Overlapping Impacts of HIV/COVID-19 Pandemic on HIV Vaccine Development |
Seyi Samson Enitan, Surajudeen Alim Junaid, Richard Yomi Akele |
| 39 |
[GO] |
2021―Jan―28 |
Understanding Rapid Transmitting, Invasive, Corona Pandemics through (Aair), (IS::Tn::IS), Crispr/Cas-9 DNA Editing |
Nitosh Kumar Brahma |
